ConductScience.org, home
An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.
API referenceFor AI assistants

Trial · NCT02598960

Adverse events4,108

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 4,108

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersPart A: BMS-986156 10mg04
otherAnaemiaBlood and lymphatic system disordersPart A: BMS-986156 30mg06
otherAnaemiaBlood and lymphatic system disordersPart A: BMS-986156 100mg04
otherAnaemiaBlood and lymphatic system disordersPart A: BMS-986156 240mg06
otherAnaemiaBlood and lymphatic system disordersPart A: BMS-986156 800mg19
otherAnaemiaBlood and lymphatic system disordersPart C: BMS-986156 240mg13
otherAnaemiaBlood and lymphatic system disordersPart C: BMS-986156 800mg02
otherAnaemiaBlood and lymphatic system disordersPart B: BMS-986156 30mg +Nivo 240mg13
otherAnaemiaBlood and lymphatic system disordersPart B: BMS-986156 100mg +Nivo 240mg09
otherAnaemiaBlood and lymphatic system disordersPart B: BMS-986156 240mg +Nivo 240mg314
otherAnaemiaBlood and lymphatic system disordersPart B: BMS-986156 800mg +Nivo 240mg211
otherAnaemiaBlood and lymphatic system disordersPart D: BMS-986156 240mg +Nivo 240mg30188
otherAnaemiaBlood and lymphatic system disordersPart E: BMS-986156 480mg +Nivo 480mg533
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart A: BMS-986156 10mg04
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart A: BMS-986156 30mg06
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart A: BMS-986156 100mg04
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart A: BMS-986156 240mg06
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart A: BMS-986156 800mg19
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart C: BMS-986156 240mg03
otherIncreased tendency to bruiseBlood and lymphatic system disordersPart C: BMS-986156 800mg02

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02598960/events

API referenceFor AI assistants